50
Participants
Start Date
November 30, 2013
Primary Completion Date
August 31, 2016
Study Completion Date
August 31, 2016
Sotatercept
Sotatercept is dosed intravenously every 14 days. The dose a subject receives will depend on the randomization arm and the dose group.
Sotatercept
Sotatercept is dosed subcutaneously every 14 days. The dose a subject receives will depend on the randomization arm and the dose group.
Universitaire Ziekenhuizen (UZ) Leuven - Gasthuisberg, Leuven
CHR de la CITADELLE, Liège
Centre Hospitalier EpiCURA - Clinique Louis Caty de Baudour, Baudour
Nephrocare Faro, Faro
Hospital Universitario Reina Sofia, Córdoba
Servicio de Nefrologia Hospital General Universitario Gregorio Maranon, Madrid
Hospital 12 de Octubre, Madrid
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid
Hospital Universitario Marques de Valdecilla, Santander, Cantabria
Gemeinschaftspraxis und Dialysezentrum Karlstrass, Düsseldorf
Hospital Galdakao-Usansolo, Galdakao
KfH Kuratorium für Dialyse und Nierentransplantation e.v., München
KfH Nierenzentrum Rosenheim, Rosenheim
KfH Nierenzentrum Coburg, Coburg
Hospital de Santa Maria, Lisbon
Nephrocare Portimao, Portimão
Complejo Hospitalario de Torrecardenas, Almería
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinic of Barcelona, Barcelona
Hospital de Torrevieja, Torrevieja (Alicante)
Cambridge University Hospitals NHS Trust, Cambridge
Glasgow Royal Infirmary, Glasgow
St Georges Healthcare NHS Trust, London
Lead Sponsor
Celgene
INDUSTRY